Emma McCance appointed as a formulation chemist for SpectrumX
As part of plans to expand its in-house technical team, SpectrumX has appointed Emma McCance as a formulation chemist.
McCance will be responsible for developing and optimising product formulations for the UK-based healthcare and pharmaceutical company. Specifically, she will focus on developing the business’ proprietary formulation of stabilised hypochlorous acid (HOCl) for skincare.
SpectrumX is looking to develop a HOCl-based cosmetic line, with the skincare ingredient gaining popularity due to its purposed benefits for conditions such as acne, eczema and psoriasis.
In the appointment announcement, the company announced its intentions to build a robust in-house technical team with a deep knowledge of molecular compounds. McCance thus brings a breadth of expertise in product development and quality control.
With more than six years of experience as a chemist, McCance joins SpectrumX from MPM Consumer Products Ltd, a manufacturer of household and personal care products, where she worked as a formulation chemist for cosmetics. She holds a BSc in chemistry from the University of Huddersfield.
In her new role, McCance will focus especially on product performance, safety, and efficacy. She will also source ingredients, create prototypes, scale products for manufacture and ensure that products meet the necessary regulatory requirements. McCance will report to SpectrumX’s technical manager, Annaliese Waite.
“I am excited to join SpectrumX and to contribute to the development of safe, effective cosmetics products based on the novel properties of HOCl,” said Emma McCance in a press statement. “The cosmetics industry is just beginning to scratch the surface on what HOCl can bring to the cosmetics market, and I look forward to combining my expertise with SpectrumX’s scientific breakthroughs to bring this innovation to market.”
“We are thrilled to welcome Emma, who will play a pivotal role in building the in-house expertise to innovate and develop our cosmetics line, which has the largest scope of product possibilities,” commented the chief executive of SpectrumX, Damien Hancox. “Emma’s experience in formulation and in-depth knowledge of molecular ingredient compatibility will be an asset as we create a line of products to cleanse, tone, and repair skin for future rollout across B2B and B2C markets.”
